Successful Application of Extracorporeal Membrane Oxygenation for a Patient with Clinical Amniotic Fluid Embolism
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Amniotic fluid embolism (AFE) is a rare but potentially fatal complication that occurs acutely during pregnancy or within 12 h of delivery. The management of AFE focuses initially on supportive measures for cardiopulmonary stabilization. Extracorporeal membrane oxygenation should be considered in patients who are unresponsive to medical treatment in order to prevent additional hypoxia and subsequent organ failure. We present a 41-year-old woman with clinical AFE who developed acute respiratory distress syndrome and was treated successfully with extracorporeal membrane oxygenation.
Abstract
Amniotic fluid embolism (AFE) is a rare but potentially fatal complication that occurs acutely during pregnancy or within 12 h of delivery. The management of AFE focuses initially on supportive measures for cardiopulmonary stabilization. Extracorporeal membrane oxygenation should be considered in patients who are unresponsive to medical treatment in order to prevent additional hypoxia and subsequent organ failure. We present a 41-year-old woman with clinical AFE who developed acute respiratory distress syndrome and was treated successfully with extracorporeal membrane oxygenation.
참고문헌 (16)
- Kanayama N, "Amniotic fluid embolism:pathophysiology and new strategies for management", J Obstet Gynaecol Res, 40, pp.1507~1517 (2014)
- Moore J, "Amniotic fluid embolism", Crit Care Med, 33(10 Suppl), pp.S279~S285 (2005)
- Clark SL, "Amniotic fluid embolism: analysis of the national registry", Am J Obstet Gynecol, 172(4 Pt 1), pp.1158~1167 (1995)
- Clark SL, "Amniotic fluid embolism", Obstet Gynecol, 123(2 Pt 1), pp.337~348 (2014)
- Conde-Agudelo A, "Amniotic fluid embolism:an evidence-based review", Am J Obstet Gynecol, 201, pp.445.e1~445.e13 (2009)
- Pantaleo G, "Amniotic fluid embolism: review", Curr Pharm Biotechnol, 14, pp.1163~1167 (2014)
- de Swiet M, "Maternal mortality: confidential enquiries into maternal deaths in the United Kingdom", Am J Obstet Gynecol, 182, pp.760~766 (2000)
- Yoneyama K, "Clinical characteristics of amniotic fluid embolism: an experience of 29 years", J Obstet Gynaecol Res, 40, pp.1862~1870 (2014)
- Ho CH, "Early application of extracorporeal membrane oxygenation in a patient with amniotic fluid embolism", Acta Anaesthesiol Taiwan, 47, pp.99~102 (2009)
- Hsieh YY, "Successful application of extracorporeal membrane oxygenation and intra-aortic balloon counterpulsation as lifesaving therapy for a patient with amniotic fluid embolism", Am J Obstet Gynecol, 183, pp.496~497 (2000)
- Ecker JL, "Case records of the Massachusetts General Hospital. Case 40-2012. A 43-year-old woman with cardiorespiratory arrest after a cesarean section", N Engl J Med, 367, pp.2528~2536 (2012)
- Reyftmann L, "Extracorporeal membrane oxygenation therapy for circulatory arrest due to postpartum hemorrhage", Obstet Gynecol, 107(2 Pt 2), pp.511~514 (2006)
- Ito F, "Incidence, diagnosis and pathophysiology of amniotic fluid embolism", J Obstet Gynaecol, 34, pp.580~584 (2014)
- Uszyński M, "Tissue factor (TF) and tissue factor pathway inhibitor (TFPI) in amniotic fluid and blood plasma: implications for the mechanism of amniotic fluid embolism", Eur J Obstet Gynecol Reprod Biol, 95, pp.163~166 (2001)
- Allen S, "A review of the fundamental principles and evidence base in the use of extracorporeal membrane oxygenation (ECMO) in critically ill adult patients", J Intensive Care Med, 26, pp.13~26 (2011)
- Sharma NS, "Modern use of extracorporeal life support in pregnancy and postpartum", ASAIO J, 61, pp.110~114 (2015)